Liu, Y., Wang, S., Schubert, M., Lauk, A., Yao, H., Blank, M. F., . . . Müller-Tidow, C. (2022). CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cells. International journal of cancer, 150(7), . https://doi.org/10.1002/ijc.33865
Chicago-Zitierstil (17. Ausg.)Liu, Yi, et al. "CD33-directed Immunotherapy with Third-generation Chimeric Antigen Receptor T Cells and Gemtuzumab Ozogamicin in Intact and CD33-edited Acute Myeloid Leukemia and Hematopoietic Stem and Progenitor Cells." International Journal of Cancer 150, no. 7 (2022). https://doi.org/10.1002/ijc.33865.
MLA-Zitierstil (9. Ausg.)Liu, Yi, et al. "CD33-directed Immunotherapy with Third-generation Chimeric Antigen Receptor T Cells and Gemtuzumab Ozogamicin in Intact and CD33-edited Acute Myeloid Leukemia and Hematopoietic Stem and Progenitor Cells." International Journal of Cancer, vol. 150, no. 7, 2022, https://doi.org/10.1002/ijc.33865.